Talaris Therapeutics, Inc. (TALS) Social Stream



Talaris Therapeutics, Inc. (TALS): $4.53

-0.50 (-9.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TALS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Talaris Therapeutics Inc (TALS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Talaris Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 4 $35 $21 $29.25 $9.24 216.56%
2022-01-28 4 $35 $22 $29.5 $9.24 219.26%
2022-03-17 4 $35 $20 $25.75 $9.24 178.68%
2022-03-22 4 $35 $21 $26 $9.24 181.39%

The Trend in the Analyst Price Target


TALS's average price target has moved down $3.25 over the prior 28 weeks.

TALS reports an average of 122.12% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 NA 35 21 27.33 17.47 56.44%
2021-07-10 3 35 21 29.25 13.44 117.63%
2021-08-01 3 35 21 29.25 13.81 111.8%
2021-08-28 3 35 21 29.25 13.02 124.65%
2021-11-12 4 35 22 29.50 15.98 84.61%

TALS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 3 1 0 0 0 4

The Trend in the Broker Recommendations


Over the past 39 weeks, TALS's average broker recommendation rating improved by 0.08.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TALS as an investment opportunity.

  • TALS has a greater upside potential (average analyst target price relative to current price) than 351.72% of all US stocks.
  • In the context of all US stocks, Talaris Therapeutics Inc's number of analysts covering the stock is greater than 76.2% of them.
  • In the context of stocks in the small market cap category, Talaris Therapeutics Inc's variance in analysts' estimates is lower than -168.53% of them.
  • Talaris Therapeutics Inc's average analyst price target is greater than 253.71% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Talaris Therapeutics Inc are SURF, STRO, and SRZN.

Is TALS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5608 seconds.